Cleveland, OH and Basking Ridge, NJ (PRWEB) November 21, 2011
ProEd Communications, part of the Healthcare Consultancy Group, has appointed John R. Cutt, PhD, as Vice President, Global Regulatory Affairs. Dr. Cutt will be responsible for expanding the regulatory business and service offerings worldwide.
In making this announcement, Marta Brooks, PharmD, President of ProEd said, “We could not be more excited to have John join our team. John brings a broad range of expertise, and his addition to the team will help deepen our core expertise, expand our range of service offerings, and further extend our services worldwide
Mary Rofael, MD, RACCOO, Scientific and Regulatory Services for ProEd commented, John brings an invaluable perspective to ProEds clients. He has successfully led some of the most challenging interactions with health authorities and has worked in the most competitive drug development settings. As a long-term client, I have observed first-hand how he has superbly managed the critical communications needs in those settings.
Dr. Cutt joins ProEd in their Basking Ridge, New Jersey, offices from Novartis Pharmaceuticals Corporation, where he held fourth-year positions in global regulatory affairs. He has a PhD in molecular microbiology and began his career in regulatory 20 years ago at the Schering-Plough Research Institute.
Dr. Cutt has a wealth of integrated regulative, drug development, and commercial experience in a broad range of alterative areas including immunology, gastrointestinal, oncology, respiratory, arthritis, pain, bone, urology, anti-infective, transplantation, and womens health. He has early development experience in over twenty biologic compounds, including cytokines, monoclonal antibodies, gene therapy, peptides, and orally delivered biologics. This impressive background will enhance ProEds formidable record of providing its clients with the highest quality of work in the regulatory area.
We are investing in regulatory by hiring John, as we believe we can leverage the learnings from our regulatory group into making a more seamless, cost-effective transition from approval to commercialization for our clients, said Denise Bottiglieri, PhD, CEO of the Healthcare Consultancy Group. Dr. Bottiglieri added, We have the distinct advantage in cognized the data, what the thought leaders think firsthand, and the regulatory environment. This puts us in a position to be effective and innovative in helping our clients deriving a competitive edge when launching their products. No other group can claim this.
ABOUT ProEd Communications (ProEd)
ProEd Communications, Inc., (http://www.proedcom.com) a fully integrated healthcare communications company, was constituted in 1991 to provide first-class planetary health communications to the healthcare industry worldwide (pharmaceutical, biotechnology, device, healthcare professional associations, etc). But we are much more than that: We are a group of dedicated medical communications professionals who inferring that science is a way of thinking and that excellence is an attitude, not an one-time achievement. ProEd’s reputation is the result of successfully meeting clients’ diverse needs.
ABOUT Healthcare Consultancy Group (HCG)
When it comes to science, were in our element.
The Healthcare Consultancy Group (http://www.hcgrp.com) is composed of a group of independently managed healthcare communications companies dedicated to delivering accurate, strategical, and compelling scientific communications.
As one of the largest and most established providers in the country, our world-class healthcare communications organization has offices in New York, NY; Basking Ridge, NJ; Stamford, CT; Cleveland, OH; and San Francisco, CA; and has partners in Europe, Asia/Pacific, and Latin America.
The integrated healthcare communications companies of HCG are: